- The folks at Ohio State University Comprehensive Cancer Center are studying the effects of propranolol hydrochloride; Correlative Studies on Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer, Stage IV Melanoma, Stage IV Ovarian Epithelial Cancer, Stage IV Ovarian Germ Cell Tumor and Unspecified Adult Solid Tumor, Protocol Specific in individuals ages 18 years and older. This clinical trial is slated to start January 2014.1-800-293-5066 The Ohio State University Comprehensive Cancer Center
|Recruiting||The Ohio State University Comprehensive Cancer Center||Jamesline@osumc.edu||1-800-293-5066|
This study is officially titled, "A Pilot Study of Beta-Blockers in Patients With Advanced Cancer."
|Recruiting||Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center|
Columbus, Ohio, 43210
United States - map
|William E. Carson||614-293-6306|
For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.